Oral News and Research

RSS

Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant

Systemic therapy consisting of corticosteroids and immunosuppressants preserved vision of uveitis patients better - and had fewer adverse outcomes - than a long-lasting corticosteroid intraocular implant, according to a clinical trial funded by the National Eye Institute.

9 May 2017

Study finds effective treatment approach for preserving long-term vision in patients with severe uveitis

Researchers comparing leading treatment approaches for patients with severe uveitis have discovered that systemic therapy with oral corticosteroids and immunosuppression can preserve or improve vision in the long term better than regional implant therapy can.

8 May 2017

Steroids offer no additional relief to emergency patients suffering from hives

Despite standard use for the itching associated with urticaria (commonly known as hives), prednisone (a steroid) offered no additional relief to emergency patients suffering from hives than a placebo did, according to a randomized, placebo-controlled, double-blind, parallel-group study published online yesterday in Annals of Emergency Medicine.

4 May 2017

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Merck announced the presentation of new analyses of efficacy and safety data for investigational Cladribine Tablets in poster presentations at the Annual Meeting of the American Academy of Neurology (AAN), that took place April 22 – 28, 2017, in Boston, Massachusetts.

3 May 2017

Microthreaded dental implants preserve crestal bone

Journal of Oral Implantology – Tooth loss is not simply an aesthetic problem for adults. It can have severe consequences to overall dental health, including complications with speech, eating, and overcompensation of mouth due to the deficiency.

3 May 2017

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

The first European study into the burden of non-tuberculosis mycobacterium pulmonary disease (NTM-PD), published today in the European Respiratory Journal, has revealed that both the 3-year all-cause mortality rate and financial burden for patients with the disease is almost four times higher than a matched control group.

2 May 2017

LSUHealthNO receives NIH grant to develop novel long-lasting dental filling materials

The National Institute of Dental and Craniofacial Research of the National Institutes of Health has awarded LSU Health New Orleans' School of Dentistry an R01 grant in the amount of $2,465,297 over five years to develop stronger, longer-lasting dental filling materials with antibacterial properties to inhibit recurrent cavities and extend the life of the restoration.

2 May 2017

Alcohol consumption linked to elevated risk of breast cancer in African-American women

Alcohol consumption was associated with an increased risk of breast cancer in a large study of African-American women, indicating that they, like white women, may benefit from limiting alcohol.

1 May 2017

Study shows microthreaded dental implants can minimize crestal bone loss

29 Apr 2017

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

28 Apr 2017

Glycated CD59 identified as novel biomarker for screening and diagnosis of gestational diabetes

Mellitus, LLC today reported the publication of results from a prospective, investigator-initiated study conducted at Brigham and Women's Hospital demonstrating the potential clinical utility of glycated CD59 (GCD59) as a novel biomarker for the screening and diagnosis of gestational diabetes mellitus.

28 Apr 2017

New study makes wireless medical electronics for treating the GI tract one step closer to reality

Imagers, gastric pacemakers and other diagnostic and therapeutic tools could someday transform the way diseases of the gastrointestinal tract are measured and treated. But in order for these electronic devices to work, they need a power source.

27 Apr 2017

Nose2Brain project aims to develop better therapy for multiple sclerosis

Medically active substances are normally distributed via the blood - either directly by injection into the bloodstream or indirectly, for example through the digestive tract after oral administration.

27 Apr 2017

New blood test could help identify women at higher risk for developing gestational diabetes

A new study led by researchers at Brigham and Women's Hospital has found that a single measurement of plasma glycated CD59 (GCD59), a novel biomarker for diabetes, at weeks 24-28 of gestation identified, with high sensitivity and specificity, women who failed the glucose challenge test as well as women with gestational diabetes.

27 Apr 2017

Scientists aim to combat antibiotic-resistant infections by harnessing synthetic mucus

Researchers are pursuing an innovative and unexpected new avenue in the quest to fight antibiotic resistance: synthetic mucus. By studying and replicating mucus' natural ability to control pathogenic bacteria, the scientists hope to find new methods for combating infections.

26 Apr 2017

Scientists find way to provide longer-lasting pain relief using MOFs

To treat headaches, back pain or fever, most of us have reached for ibuprofen at one point or another. But we often have to take doses every four to six hours if the pain warrants it.

26 Apr 2017

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

26 Apr 2017

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center - Biological Defense Research Directorate, Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages -- viruses that target and consume specific strains of bacteria -- to treat a patient near death from a multidrug-resistant bacterium.

25 Apr 2017

Enzyme treatment may prevent or reduce liver damage caused by excess alcohol consumption

An intestinal enzyme previously shown to keep bacterial toxins from passing from the gastrointestinal system into the bloodstream may be able to prevent or reduce the liver damage caused by excess alcohol consumption.

25 Apr 2017

Intraoperative methadone offers promise to reduce need for pain medications during recovery

Patients undergoing spinal fusion surgery who are treated with methadone during the procedure require significantly less intravenous and oral opioids to manage postoperative pain, reports a new study published in the May issue of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.

24 Apr 2017

Oral News and Research

Study: Systemic therapy preserves vision of uveitis patients better than intraocular implant

Study finds effective treatment approach for preserving long-term vision in patients with severe uveitis

Steroids offer no additional relief to emergency patients suffering from hives

Merck presents data on investigational cladribine tablets in relapsing multiple sclerosis

Microthreaded dental implants preserve crestal bone

New analysis shows high mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium (NTM)

LSUHealthNO receives NIH grant to develop novel long-lasting dental filling materials

Alcohol consumption linked to elevated risk of breast cancer in African-American women

Study shows microthreaded dental implants can minimize crestal bone loss

Takeda announces accelerated approval from FDA for new lung cancer treatment

Glycated CD59 identified as novel biomarker for screening and diagnosis of gestational diabetes

New study makes wireless medical electronics for treating the GI tract one step closer to reality

Nose2Brain project aims to develop better therapy for multiple sclerosis

New blood test could help identify women at higher risk for developing gestational diabetes

Scientists aim to combat antibiotic-resistant infections by harnessing synthetic mucus

Scientists find way to provide longer-lasting pain relief using MOFs

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Researchers use novel phage therapy to treat patient infected with multidrug-resistant bacterium

Enzyme treatment may prevent or reduce liver damage caused by excess alcohol consumption

Intraoperative methadone offers promise to reduce need for pain medications during recovery

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News